Commentary Open Access
Volume 5 | Issue 2 | DOI: https://doi.org/10.33696/Signaling.5.116
Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges
Yuting Wang1, Peiran Chen1, Ming-Liang He1,*
- 1Department of Biomedical Sciences, City University of Hong Kong, China
Corresponding Author
Ming-Liang He, mlhe7788@gmail.com
Received Date: April 04, 2024
Accepted Date: June 11, 2024
Wang Y, Chen P, He ML. Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges. J Cell Signal. 2024;5(2):91-95.
Copyright: © 2024 Wang Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
The Finer Points of Podocyte Sphingolipid Metabolism in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a common complication of diabetes, characterized by kidney damage. Podocytes are specialized, terminally differentiated cells in the kidney’s filtration barrier that are key responders to the metabolic and environmental changes that occur in diabetes. Change in the function and in the number of podocytes is the main signature of the development and progression of DKD.
Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), although has faded from public view, the virus itself remains highly active and continues to mutate, continuously causing infections. The population faces the risk of severe outcomes caused by virus infection (e.g., multi-organ tissue injury and acute respiratory distress syndrome (ARDS)). Furthermore, patients with chronic diseases (cardiovascular diseases, diabetes) are at risk of developing severe sequelae or even elevated mortality.